Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Teclison
26 Park Street, Suite 100
Montclair, NJ 07042
https://www.teclison.com/

Teclison is a clinical-stage biotechnology company developing innovative cancer therapeutics to induce tumor necrosis and enhance anti-tumor immunity. The company's portfolio is comprised of new approaches aimed at enhancing the therapeutic benefit of tumor embolization and immunotherapy to treat nearly all solid cancers.

Key Contact
Name
Ray Lee
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
02/14/22 $5,900,000 Nestor Capital
W.T.T. Investment
undisclosed


Featured Reading